Cryomedics, Inc. v. Spembly, Limited

397 F. Supp. 287, 188 U.S.P.Q. (BNA) 255, 1975 U.S. Dist. LEXIS 11937
CourtDistrict Court, D. Connecticut
DecidedJune 11, 1975
DocketCiv. B-74-453
StatusPublished
Cited by45 cases

This text of 397 F. Supp. 287 (Cryomedics, Inc. v. Spembly, Limited) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cryomedics, Inc. v. Spembly, Limited, 397 F. Supp. 287, 188 U.S.P.Q. (BNA) 255, 1975 U.S. Dist. LEXIS 11937 (D. Conn. 1975).

Opinion

RULING ON DEFENDANTS’ MOTION TO DISMISS

NEWMAN, District Judge.

This motion to dismiss presents in an unusual procedural posture an important question of the reach of this Court’s in personam jurisdiction. Plaintiff Cryomedics, Inc. (“Cyromedies”) is a Connecticut corporation engaged in the manufacture and sale of cryosurgical instruments that are sold to hospitals and surgeons. Defendants Spembly, Limited *288 and Spembly Technical Products, Limited (referred to jointly as “Spembly”) are incorporated under the laws of Great Britain and have their principal place of business in England. Spembly is also engaged in the manufacture and sale of cryosurgical instruments. This action arises under the patent laws of the United States, 35 U.S.C. §§ 271, 281. In the first three counts of its complaint, Cryomedics charges that Spembly has infringed, actively induced the infringement, and contributed to the infringement of its United States patent 3,696,813 (“the '813 patent”), in violation of 35 U.S.C. § 271. Count IV seeks a declaration that Spembly's United States patent 3,502,081 (“the ’081 patent”) in invalid and not infringed by Cryomedics. 1 28 U.S.C. § 2201. Spembly has moved to dismiss all four counts on the ground that it is not subject to the in personam jurisdiction of this Court, Fed.R.Civ.P. 12(b)(2). Spembly has also moved to dismiss Count IV on the ground that there is no justiciable controversy between it and Cryomedics with respect to the ’081 patent, and that this Court therefore lacks jurisdiction over the subject matter, Fed.R.Civ.P. 12(b)(1).

With respect to in personam jurisdiction, Spembly does not now contest Cryomedics’ claim that the Connecticut corporate long-arm statute, Conn.Gen. Stat. § 33-411(c), provides a basis for service of process on it. See Fed.R.Civ. P. 4(e), 4(i)(l)(D) 2 Section 33-411(c) has been construed “to extend Connecticut’s jurisdictional reach to the constitutional limits,” Electric Regulator Corp. v. Sterling Extruder Corp., 280 F.Supp. 550, 556 (D.Conn.1968), and Spembly’s sole remaining challenge to this Court’s exercise of personal jurisdiction over it is the claim that the application of the statute to it is unconstitutional.

The argument as advanced by Spembly is based on two propositions: first, that International Shoe Co. v. Washington, 326 U.S. 310, 66 S.Ct. 154, 90 L.Ed. 95 (1945), requires that as a predicate to this Courts jurisdiction Spembly have certain “minimum contacts” with the State of Connecticut, 3 and second, that its contacts with the State are insufficient to satisfy International Shoe’s due process standards. 4 To establish the second proposition Spembly relies almost exclusively on the District Court decision in Honeywell, Inc. v. Metz Apparatewerke, 353 F.Supp. 492 (N.D.Ill.1972). Honeywell has been reversed, however, 509 F.2d 1137 (7th Cir. 1975), and although it still provides a useful basis for comparison, it is no longer controlling.

*289 Cryomedics resists the claim of insufficient contacts on two fronts. It contends, first, that it has alleged sufficient contacts with Connecticut to meet the constitutional requirements, see note 3, swpra, and, second, that Spembly’s status as an alien permits this Court to consider the aggregate of Spembly’s contacts with the United States as a whole. See Honeywell v. Metz, supra, 509 F.2d at 1143 n. 2.

Taking as true the allegations of the complaint as supplemented by affidavit and particularized in Cryomedics’ memorandum, Spembly has the following contacts with Connecticut. 5 Storz Instrument Co., described as a “sub or dealer under” Keeler, Inc., one of Spembly’s two primary distributors in the United States, has at least one salesman who solicits in Connecticut. Storz has offered infringing and other Spembly equipment for sale in Connecticut. Keeler itself has made at least one sale in Connecticut of Spembly equipment, although the complaint does not allege the sale was of equipment that infringes the ’813 patent. Elmed, Inc., Spembly’s other primary American distributor, also has representatives who solicit and who have sold at least one item of infringing Spembly equipment in Connecticut. Cryomedics also alleges that Spembly has caused Elmed and Keeler to sue Cryomedics in Connecticut, that a director of Spembly met once in Connecticut with Cryomedics’ president, and that Spembly has a Connecticut licensee that apparently is independent of Spembly and does not manufacture or deal in Spembly equipment. Spembly, of course, describes these contacts in more limited terms and disputes the significance of those that it admits. Other than the charges of voluntary involvement in litigation in Connecticut, and the related allegation that Spembly has agreed to indemnify its distributors for losses incurred in defending and prosecuting the patent actions, Cryomedics has offered no evidence of the relationship between Spembly and its distributors.

In Honeywell v. Metz, supra, the Court observed that there is no easy formula for determining whether contacts are sufficient to comply with due process, and that a court must determine on a case-by-case basis whether a non-resident defendant “can be said to have invoked, by act or conduct, the benefits and protection of the laws of the forum.” 509 F.2d at 1144. See International Shoe v. Washington, supra; Hanson v. Denckla, 357 U.S. 235, 253, 78 S.Ct. 1228, 2 L.Ed.2d 1283 (1958). Metz was found to have availed itself of the protection of Illinois law by injecting its products into the stream of commerce “under such circumstances that it should reasonably have anticipated that injury through infringement” would occur in Illinois, 509 F.2d at 1144.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Jarrow Formulas, Inc. v. International Nutrition Co.
175 F. Supp. 2d 296 (D. Connecticut, 2001)
Eason v. Linden Avionics, Inc.
706 F. Supp. 311 (D. New Jersey, 1989)
Diversified Marketing, Inc. v. Estee Lauder, Inc.
705 F. Supp. 128 (S.D. New York, 1988)
US Telecom, Inc. v. Hubert
678 F. Supp. 1500 (D. Kansas, 1987)
King v. McAllister Bros., Inc.
659 F. Supp. 39 (S.D. Alabama, 1987)
A.J. Canfield Co. v. Concord Beverage Co.
629 F. Supp. 200 (E.D. Pennsylvania, 1985)
Warren Corp. v. Goldwert Textile Sales, Inc.
581 F. Supp. 897 (S.D. New York, 1984)
Max Daetwyler Corp. v. Meyer
575 F. Supp. 280 (E.D. Pennsylvania, 1983)
Medeco Security Locks, Inc. v. Fichet-Bauche
568 F. Supp. 405 (W.D. Virginia, 1983)
WSM, Inc. v. Hilton
545 F. Supp. 1212 (W.D. Missouri, 1982)

Cite This Page — Counsel Stack

Bluebook (online)
397 F. Supp. 287, 188 U.S.P.Q. (BNA) 255, 1975 U.S. Dist. LEXIS 11937, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cryomedics-inc-v-spembly-limited-ctd-1975.